Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-657

there are other products that detect the virus on the asx and shareholders of them will try to negatively rubbish this product on hot copper i believe this product is better its quicker probably cheaper and can test far far more people in a day //turn down the noise

Combatting COVID-19
Proceeds from the placement and SPP will be used to fund the roll-out of the SARSCoV-2 diagnostic tests and general working capital.
The company recently announced it will supply rapid diagnostic tests (RDT), with products expected to arrive in the country early this month.
This test uses a virus-specific detection method that delivers results anywhere between three to 15 minutes and requires no laboratory equipment
It also does not require the use of Polymerase chain reaction (PCR) equipment, which is one of the limiting factors in wide-scale testing.
The Australian pathology system is also limited by the lack of reagents and the rapid tests may help remove this bottleneck.